Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Thornhill Medical, a company that spun off from UHN 15 years ago, recently completed its Series A financing round. Completion of this round of funding requires companies to demonstrate solid market success – an important milestone that requires an enormous amount of work and perseverance.
Thornhill Medical makes innovative healthcare devices and has been awarded more than 40 patents.
The company was founded by
Dr. Joseph Fisher, a Senior Scientist at the Toronto General Hospital Research Institute, and a world-renowned researcher in the field of cardio-respiratory physiology and neurovascular research. He's Thornhill's Chief Scientist and a Director. Dr. Ludwik Fedorko, his colleague in the Department of Anesthesiology at UHN, is a Senior Scientist and Director with the company.
Since spinning off from UHN in 2003, Thornhill Medical has built upon their expertise to develop and manufacture a compact mobile life support system used by the United States military to treat field casualties and other emergency respiration and anesthesia devices.
In addition, Thornhill Medical has developed a device that is a portable treatment for carbon monoxide poisoning, and a device used with MRI scanning to examine brain and heart blood vessel function with a view to predicting the risk for stroke and heart attack.
The funding was provided by Yonghua Investment Management Co., Ltd. ("Yonghua Capital") of Shanghai, China – an experienced private equity investor, which has invested in more than 100 outstanding companies, among which nearly 60 have been listed with stock exchanges.
"The financial investment focus of the Yonghua Capital compliments Thornhill's approach to clinical research, product development and global commercialization," says Kipton Lade, President & CEO of Thornhill Medical.
"We are excited to partner with such a dynamic and well-managed professional team as we continue our mission to deliver unique medical devices, using the lung as a portal, to transform current diagnostic and therapeutic patient care."
Thornhill Medical will use the funding to support its market released line of emergency mobile products, expand its global sales and marketing presence and continue clinical research in the fields of non-invasive cardiac and brain stress testing.
Read more about Thornhill Medical's completion of key funding.